| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc217294420329c230b71b98d64c4e83 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
| filingDate |
2015-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abb7c8dcb45649e8236ead090d0abfee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_769c209f2c87642ea609415e86337e12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e9f3748636438cd008ba626c0c68fe |
| publicationDate |
2017-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2015009504-A |
| titleOfInvention |
PHARMACEUTICAL COMPOSITION OF DESLORATADINE TO BE ADMINISTERED BY ORAL, FOR THE TREATMENT OF DISEASES RELATED TO HISTAMINE. |
| abstract |
The present invention consists of a pharmaceutical composition to be administered orally and used for the treatment of problems related to histamine, without the use of both lactose, the use of a disintegrant, and with the addition of a pharmaceutically acceptable agent that allows Desloratadine protection. |
| priorityDate |
2015-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |